Grupo farmacéutico · Estados Unidos
Baxter
Un grupo de 45 empresas con 1205 medicamentos en 11 países.
Estructura del grupo
45 empresas en 22 países
Cargando…
Grupo farmacéutico · Estados Unidos
Un grupo de 45 empresas con 1205 medicamentos en 11 países.
45 empresas en 22 países
Una cuenta gratuita para las apps de Prognia: Ward para estudiar, Osler para respuestas clínicas con sus fuentes y la red para encontrar a tus colegas.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Todos los medicamentos de todas las empresas del grupo, primero los vigentes.
1–25 de 1205
| Medicamento | Principio activo | País | Estado | Autorización |
|---|---|---|---|---|
| 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION50 mg / ml + 4 mg / ml · Solution | Dextrose, Lidocaine | Canadá | Comercializado | 1990 |
| 0.9% SODIUM CHLORIDE INJECTION, USP900 mg / 100 ml · Solution | Sodium chloride | Canadá | Comercializado | 1982 |
| 0.9% SODIUM CHLORIDE IRRIGATION, USP900 mg / 100 ml · Solution | Sodium chloride | Canadá | Comercializado | 1989 |
| 10% DEXTROSE INJECTION, USP10 g / 100 ml · Solution | Dextrose | Canadá | Comercializado | 1997 |
| 10 mEq Potassium Chloride in 5% Dextrose and 0.33% Sodium Chloride Injection, USP50 g/L + 1.5 g/L + 3.3 g/L · Injection | Hydrous dextrose, Potassium chloride, Sodium chloride | Singapur | Autorizado | 2006 |
| 12% SODIUM CHLORDIE PROCESSING SOLUTION12 g / 100 ml · Solution | Sodium chloride | Canadá | Comercializado | 1991 |
| (20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP3.3 g / 100 ml + 150 mg / 100 ml + 300 mg / 100 ml · Solution | Dextrose, Potassium chloride, Sodium chloride | Canadá | Comercializado | 1978 |
| (20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP5 g / 100 ml + 150 mg / 100 ml + 900 mg / 100 ml · Solution | Dextrose, Potassium chloride, Sodium chloride | Canadá | Comercializado | 1990 |
| (20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP5 g / 100 ml + 150 mg / 100 ml · Solution | Dextrose, Potassium chloride | Canadá | Comercializado | 1989 |
| 20% PROSOL2.76 g / 100 ml + 1.96 g / 100 ml + 0.76 g / 100 ml + 1.02 g / 100 ml + 2.06 g / 100 ml + 1.18 g / 100 ml + 1.08 g / 100 ml + 0.6 g / 100 ml + 1.08 g / 100 ml + 1.35 g / 100 ml + 1 g / 100 ml + 1.34 g / 100 ml + 1.02 g / 100 ml + 0.98 g / 100 ml + 0.32 g / 100 ml + 0.05 g / 100 ml + 1.44 g / 100 ml · Liquid | Alanine, Arginine, Dl-methionine, Glutamic acid, Glycine, Histidine, Isoleucine, L-aspartic acid, Leucine, Lysine, Phenylalanine, Proline, Serine, Threonine, Tryptophan, Tyrosine, Valine | Canadá | Comercializado | 1996 |
| 20% SODIUM CHLORIDE INJECTION, BP20 % / w/v · Solution | Sodium chloride | Canadá | Comercializado | 2022 |
| (20MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP150 mg / 100 ml + 900 mg / 100 ml · Solution | Potassium chloride, Sodium chloride | Canadá | Comercializado | 1989 |
| (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP5 g / 100 ml + 150 mg / 100 ml + 450 mg / 100 ml · Solution | Dextrose, Potassium chloride, Sodium chloride | Canadá | Comercializado | 1989 |
| (40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP300 mg / 100 ml + 900 mg / 100 ml · Liquid | Potassium chloride, Sodium chloride | Canadá | Comercializado | 1989 |
| (40 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE INJECTION USP5 g / 100 ml + 300 mg / 100 ml · Solution | Dextrose, Potassium chloride | Canadá | Comercializado | 1989 |
| (40MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP3.3 g / 100 ml + 300 mg / 100 ml + 300 mg / 100 ml · Solution | Dextrose, Potassium chloride, Sodium chloride | Canadá | Comercializado | 1978 |
| (40MMOL/L)POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP5 g / 100 ml + 300 mg / 100 ml + 450 mg / 100 ml · Solution | Dextrose, Potassium chloride, Sodium chloride | Canadá | Comercializado | 1989 |
| 5% DEXTROSE INJECTION, USP5 g / 100 ml · Solution | Dextrose | Canadá | Comercializado | 1990 |
| 70% DEXTROSE INJECTION USP70 g / 100 ml · Solution | Dextrose | Canadá | Comercializado | 1995 |
| ACETAMINOPHEN INJECTION10 mg / ml · Solution | Paracetamol | Canadá | Comercializado | 2023 |
| Aciclovir Baxter 25 mg/ml, concentraat voor oplossing voor intraveneuze infusieConcentraat voor oplossing voor infusie | Aciclovir | Países Bajos | Autorizado | 2013 |
| ACIDO TRANEXAMICO BAXTER 100 MG/ML SOLUCION INYECTABLE EFG100 mg/ml · Solucion inyectable y para perfusion | Tranexamic acid | España | Autorizado | 2020 |
| AERRANE 100% LÍQUIDO PARA INHALACIÓN DEL VAPOR250 ml · Solución para inhalación del vapor | Isoflurane | España | Comercializado | 1995 |
| AERRANE INHALATION ANAESTHETIC100% · Solution | Isoflurane | Singapur | Autorizado | 1996 |
| ÁGUA ESTÉRIL BAXTER | Água para injetáveis, Água para injeção usp | Brasil | Autorizado | 1997 |
Dónde es titular o fabricante de medicamentos, y cuántos están vigentes.
| País | Medicamentos | Vigentes | Anteriores | Empresas |
|---|---|---|---|---|
| Canadá | 397 | 141 | 256 | EmpresasTodos los medicamentos |
| Arabia Saudí | 243 | 243 | 0 | EmpresasTodos los medicamentos |
| Estados Unidos | 224 | 224 | 0 | EmpresasTodos los medicamentos |
| Brasil | 85 | 29 | 56 | EmpresasTodos los medicamentos |
| España | 83 | 71 | 12 | EmpresasTodos los medicamentos |
| Países Bajos | 83 | 83 | 0 | EmpresasTodos los medicamentos |
| Singapur | 45 | 45 | 0 | EmpresasTodos los medicamentos |
| Croacia | 25 | 25 | 0 | EmpresasTodos los medicamentos |
| Rumanía | 14 | 0 | 14 | EmpresasTodos los medicamentos |
| Unión Europea (EMA) | 5 | 3 | 2 | EmpresasTodos los medicamentos |
| Italia | 1 | 1 | 0 | EmpresasTodos los medicamentos |
También en los registros de Australia, Colombia, Francia, Malasia, Reino Unido, Serbia, Suecia
Los grupos ATC a los que pertenecen la mayoría de sus medicamentos, de mayor a menor.
Los principios activos presentes en la mayoría de sus medicamentos.
Cómo lo escriben los registros, normalizado: sin forma jurídica, tildes ni mayúsculas.
Recopilado por Prognia a partir de los registros públicos de medicamentos y empresas que aparecen abajo. No se usan logotipos.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Source: European Medicines Agency (EPAR data).
Licencia: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licencia: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licencia: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licencia: Licence Ouverte v1.0
ASIC,ASIC - Company Dataset,declared13October2026 extract,CC BY3.0 Australia,https://data.gov.au/data/dataset/asic-companies. Normalized and independently classified by Prognia;no endorsement.
Licencia: Creative Commons Attribution 3.0 Australia
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licencia: Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licencia: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Licencia: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licencia: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Agência Nacional de Vigilância Sanitária (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Licencia: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licencia: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes, dataset i7cb-raxc, rowsUpdatedAt 1792152574, acquired 2026-10-26; original values retained.
Licencia: CC BY-SA 4.0
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licencia: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licencia: BDPM exact Licence Ouverte v1.0 (October 2011)
BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.
Licencia: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 register, published 7 October 2026; https://assets.publishing.service.gov.uk/media/6ac660fdec9d3aba1e0139d9/MS_Register_-_October_2026.csv; acquired 2026-10-13T22:59:02.704630+00:00; CSV-to-role/site projection is an adaptation under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; Crown copyright MHRA factual register
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licencia: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/847386/officine_autorizzate_medicinali_30.06.2026.csv; HTTP Last-Modified Wed, 01 Jul 2026 09:37:30 GMT; acquired 2026-10-13T17:21:05.166252+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
AIFA, https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv, HTTP Last-Modified Mon, 26 Oct 2026 00:02:13 GMT, acquired 2026-10-26T09:43:33.749886+00:00; factual native values retained; exact row correspondence and projections are adaptations.
Licencia: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licencia: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licencia: Italian Open Data Licence
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licencia: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licencia: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licencia: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Saudi Food and Drug Authority (SFDA), local human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licencia: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Läkemedelsverket, Sweden, Förvaringstemperatur och hållbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0)
Läkemedelsverket, Läkemedelsprodukter 21 October 2026. Exact eleven changed existing NPL product rows adapted by Prognia on 22 October 2026; original cells and both dated observations retained. No regulator endorsement.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0)
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from ACRA Information on Corporate Entities, accessed on 8 October 2026 through Data.gov.sg, under Singapore Open Data Licence version 1.0: https://data.gov.sg/open-data-licence. Structured selection and normalisation by Prognia; original UEN, field and retrieval date retained.
Licencia: Singapore Open Data Licence
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licencia: Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licencia: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Informa de un error o solicita la retiradaLas correcciones de la propia empresa son bienvenidas.
Mantenga correctos los medicamentos de Baxter en Prognia, vea cómo los consultan los profesionales y responda a lo que preguntan. Una llamada de 20 minutos, en inglés.
Reservar una llamadaGrupos farmacéuticos conocidos, cada uno con todas sus empresas.
Ordenados por su número de medicamentos.